The purpose of this study is to investigate solid tumours. This study evaluates an investigational medication to understand its effects on these conditions.
The study focuses on evaluating the safety and tolerability of the investigational medication. It also looks at how the body processes the medication, known as pharmacokinetics.
- Who can participate: Adults 18 and older with advanced solid cancers can participate. Key factors include good organ function and a specific ECOG performance status score.
- Study details: Participants will take an investigational medication by mouth every three weeks. Some may receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any active ingredients.
How understandable was the trial content above?
Hard to understand
Easy to understand